Publicaciones
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer.
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps and Eloisa Jantus-Lewintre. IJMS. 2023 Dec 18. Epub ahead of print. doi: 10.3390/ijms242417587.
Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach, Marais Mosqueda, Ester Munera-Maravilla, Rafael Sirera, Lara Navarro, Ana Blasco, Carlos Camps and Eloisa Jantus-Lewintre. IJMS. 2023 Dec 18. Epub ahead of print. doi: 10.3390/ijms242417587.
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A, Feliu I, Kovalski J, Lopez I, Rodriguez-Remirez M, Palomino-Echeverria S, Lonfgren SM, Ferrero M, Calabuig S, Ludwig IA, Lara-Astiaso D, Jantus-Lewintre E, Guruceaga E, Narayanan S, Ponz-Sarvise M, Pineda-Lucena A, Lecanda F, Ruggero D, Khatri P, Santamaria E, Fernandez-Irigoyen J, Ferrer I, Paz-Ares L, Drosten M, Barbacid M, Gil-Bazo I, Vicent S. Nat Commun. 2023 Oct 10;14(1):6332. doi: 10.1038/s41467-023-41828-z.
Macaya I, Roman M, Welch C, Entrialgo-Cadierno R, Salmon M, Santos A, Feliu I, Kovalski J, Lopez I, Rodriguez-Remirez M, Palomino-Echeverria S, Lonfgren SM, Ferrero M, Calabuig S, Ludwig IA, Lara-Astiaso D, Jantus-Lewintre E, Guruceaga E, Narayanan S, Ponz-Sarvise M, Pineda-Lucena A, Lecanda F, Ruggero D, Khatri P, Santamaria E, Fernandez-Irigoyen J, Ferrer I, Paz-Ares L, Drosten M, Barbacid M, Gil-Bazo I, Vicent S. Nat Commun. 2023 Oct 10;14(1):6332. doi: 10.1038/s41467-023-41828-z.
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma.
Torres-Martínez S, Calabuig-Fariñas S, Moreno-Manuel A, Bertolini G, Herreros-Pomares A, Escorihuela E, Duréndez-Saéz E, Guijarro R, Blasco A, Roz L, Camps C, Jantus-Lewintre E. Mol Oncol. 2023 Aug 11. doi: 10.1002/1878-0261.13505. Epub ahead of print.
Torres-Martínez S, Calabuig-Fariñas S, Moreno-Manuel A, Bertolini G, Herreros-Pomares A, Escorihuela E, Duréndez-Saéz E, Guijarro R, Blasco A, Roz L, Camps C, Jantus-Lewintre E. Mol Oncol. 2023 Aug 11. doi: 10.1002/1878-0261.13505. Epub ahead of print.
Biological insights in non-small cell lung cancer.
Rosell R, Jain A, Codony-Servat J, Jantus-Lewintre E, Morrison B, Ginesta JB, González-Cao M. Cancer Biol Med. 2023 Jun 28;20(7):500-518. doi: 10.20892/j.issn.2095-3941.2023.0108.
Rosell R, Jain A, Codony-Servat J, Jantus-Lewintre E, Morrison B, Ginesta JB, González-Cao M. Cancer Biol Med. 2023 Jun 28;20(7):500-518. doi: 10.20892/j.issn.2095-3941.2023.0108.
Clinical and technical insights of tumour mutational burden in non-small cell lung cancer.
Meri-Abad M, Moreno-Manuel A, García SG, Calabuig-Fariñas S, Pérez RS, Herrero CC, Jantus-Lewintre E. Crit Rev Oncol Hematol. 2023 Feb;182:103891.
Meri-Abad M, Moreno-Manuel A, García SG, Calabuig-Fariñas S, Pérez RS, Herrero CC, Jantus-Lewintre E. Crit Rev Oncol Hematol. 2023 Feb;182:103891.
A Sonic Hedgehog Pathway Score to Predict the Outcome of Resected Non-Small Cell Lung Cancer Patients.
Herreros-Pomares A, Doria P, Gallach S, Meri-Abad M, Guijarro R, Calabuig-Fariñas S, Camps C, Jantus-Lewintre E. A. Ann Surg Oncol. 2023 Feb;30(2):1225-1235.
Herreros-Pomares A, Doria P, Gallach S, Meri-Abad M, Guijarro R, Calabuig-Fariñas S, Camps C, Jantus-Lewintre E. A. Ann Surg Oncol. 2023 Feb;30(2):1225-1235.
On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment.
Herreros-Pomares A, Hervás D, Bagan-Debón L, Jantus-Lewintre E, Gimeno-Cardona C, Bagan J. Int J Mol Sci. 2023 Feb 9;24(4):3466.
Herreros-Pomares A, Hervás D, Bagan-Debón L, Jantus-Lewintre E, Gimeno-Cardona C, Bagan J. Int J Mol Sci. 2023 Feb 9;24(4):3466.
Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer.
Duréndez-Sáez E, Calabuig-Fariñas S, Torres-Martínez S, Moreno-Manuel A, Herreros-Pomares A, Escorihuela E, Mosqueda M, Gallach S, Guijarro R, Serna E, Suárez-Cabrera C, Paramio JM, Blasco A, Camps C, Jantus-Lewintre E. Cancers (Basel). 2022 Jun 30;14(13):3216. doi: 10.3390/cancers14133216.
Duréndez-Sáez E, Calabuig-Fariñas S, Torres-Martínez S, Moreno-Manuel A, Herreros-Pomares A, Escorihuela E, Mosqueda M, Gallach S, Guijarro R, Serna E, Suárez-Cabrera C, Paramio JM, Blasco A, Camps C, Jantus-Lewintre E. Cancers (Basel). 2022 Jun 30;14(13):3216. doi: 10.3390/cancers14133216.
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.
Jantus-Lewintre E, Massutí Sureda B, González Larriba JL, Rodríguez-Abreu D, Juan O, Blasco A, Dómine M, Provencio Pulla M, Garde J, Álvarez R, Maestu I, Pérez de Carrión R, Artal Á, Rolfo C, de Castro J, Guillot M, Oramas J, de Las Peñas R, Ferrera L, Martínez N, Serra Ò, Rosell R, Camps C.Front Oncol. 2021 Jul 26;11:695038. doi: 10.3389/fonc.2021.695038.
Jantus-Lewintre E, Massutí Sureda B, González Larriba JL, Rodríguez-Abreu D, Juan O, Blasco A, Dómine M, Provencio Pulla M, Garde J, Álvarez R, Maestu I, Pérez de Carrión R, Artal Á, Rolfo C, de Castro J, Guillot M, Oramas J, de Las Peñas R, Ferrera L, Martínez N, Serra Ò, Rosell R, Camps C.Front Oncol. 2021 Jul 26;11:695038. doi: 10.3389/fonc.2021.695038.
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies.
Palanca-Ballester C, Rodriguez-Casanova A, Torres S, Calabuig-Fariñas S, Exposito F, Serrano D, Redin E, Valencia K, Jantus-Lewintre E, Diaz-Lagares A, Montuenga L, Sandoval J, Calvo A. Cancers (Basel). 2021 Jun 16;13(12):3016. doi: 10.3390/cancers13123016.
Palanca-Ballester C, Rodriguez-Casanova A, Torres S, Calabuig-Fariñas S, Exposito F, Serrano D, Redin E, Valencia K, Jantus-Lewintre E, Diaz-Lagares A, Montuenga L, Sandoval J, Calvo A. Cancers (Basel). 2021 Jun 16;13(12):3016. doi: 10.3390/cancers13123016.
Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients.
Dong N, Moreno-Manuel A, Calabuig-Fariñas S, Gallach S, Zhang F, Blasco A, Aparisi F, Meri-Abad M, Guijarro R, Sirera R, Camps C, Jantus-Lewintre E. Cancers (Basel). 2021 Jun 12;13(12):2950. doi: 10.3390/cancers13122950
Dong N, Moreno-Manuel A, Calabuig-Fariñas S, Gallach S, Zhang F, Blasco A, Aparisi F, Meri-Abad M, Guijarro R, Sirera R, Camps C, Jantus-Lewintre E. Cancers (Basel). 2021 Jun 12;13(12):2950. doi: 10.3390/cancers13122950
Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.
Zhang F, Ferrero M, Dong N, D’Auria G, Reyes-Prieto M, Herreros-Pomares A, Calabuig-Fariñas S, Duréndez E, Aparisi F, Blasco A, García C, Camps C, Jantus-Lewintre E, Sirera R. Cancers (Basel). 2021 May 21;13(11):2514. doi: 10.3390/cancers13112514.
Zhang F, Ferrero M, Dong N, D’Auria G, Reyes-Prieto M, Herreros-Pomares A, Calabuig-Fariñas S, Duréndez E, Aparisi F, Blasco A, García C, Camps C, Jantus-Lewintre E, Sirera R. Cancers (Basel). 2021 May 21;13(11):2514. doi: 10.3390/cancers13112514.
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglytė M, Sánchez-Hernández A, de Julián Campayo M, García-Girón C, Dómine M, Blasco A, Sánchez JM, Oramas J, Bosch-Barrera J, Sala MÁ, Sereno M, Ortega AL, Chara L, Hernández B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila MÁ, Romero A. Eur J Cancer. 2021 May;149:61-72. doi: 10.1016/j.ejca.2021.02.031.
Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglytė M, Sánchez-Hernández A, de Julián Campayo M, García-Girón C, Dómine M, Blasco A, Sánchez JM, Oramas J, Bosch-Barrera J, Sala MÁ, Sereno M, Ortega AL, Chara L, Hernández B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila MÁ, Romero A. Eur J Cancer. 2021 May;149:61-72. doi: 10.1016/j.ejca.2021.02.031.
3D printing novel in vitro cancer cell culture model systems for lung cancer stem cell study.
Herreros-Pomares A, Zhou X, Calabuig-Fariñas S, Lee SJ, Torres S, Esworthy T, Hann SY, Jantus-Lewintre E, Camps C, Zhang LG. Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111914.
Herreros-Pomares A, Zhou X, Calabuig-Fariñas S, Lee SJ, Torres S, Esworthy T, Hann SY, Jantus-Lewintre E, Camps C, Zhang LG. Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111914.
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
Finn SP, Addeo A, Dafni U, Thunnissen E, Bubendorf L, Madsen LB, Biernat W, Verbeken E, Hernandez-Losa J, Marchetti A, Cheney R, Warth A, Speel EM, Quinn AM, Monkhorst K, Jantus-Lewintre E, Tischler V, Marti N, Dimopoulou G, Molina-Vila MA, Kammler R, Kerr KM, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Investigators. J Thorac Oncol. 2021 Feb 26:S1556-0864(21)01734-2.
Finn SP, Addeo A, Dafni U, Thunnissen E, Bubendorf L, Madsen LB, Biernat W, Verbeken E, Hernandez-Losa J, Marchetti A, Cheney R, Warth A, Speel EM, Quinn AM, Monkhorst K, Jantus-Lewintre E, Tischler V, Marti N, Dimopoulou G, Molina-Vila MA, Kammler R, Kerr KM, Peters S, Stahel RA; European Thoracic Oncology Platform Lungscape Investigators. J Thorac Oncol. 2021 Feb 26:S1556-0864(21)01734-2.
Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
Herreros-Pomares A, Llorens C, Soriano B, Bagan L, Moreno A, Calabuig-Fariñas S, Jantus-Lewintre E, Bagan J. Oral Oncol. 2021 Feb 28;116:105191.
Herreros-Pomares A, Llorens C, Soriano B, Bagan L, Moreno A, Calabuig-Fariñas S, Jantus-Lewintre E, Bagan J. Oral Oncol. 2021 Feb 28;116:105191.
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications.
Camps C, López R, Antón A, Aranda E, Carrato A, Cruz JJ, Cunquero-Tomás AJ, Díaz-Rubio E, Feyjóo M, García-Foncillas J, Gascón P, Lugo I, Rogado Á, Guillem V. JCO Oncol Pract. 2021 Feb 23:OP2000683.
Camps C, López R, Antón A, Aranda E, Carrato A, Cruz JJ, Cunquero-Tomás AJ, Díaz-Rubio E, Feyjóo M, García-Foncillas J, Gascón P, Lugo I, Rogado Á, Guillem V. JCO Oncol Pract. 2021 Feb 23:OP2000683.
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
Romero A, Jantus-Lewintre E, García-Peláez B, Royuela A, Insa A, Cruz P, Collazo A, Pérez Altozano J, Vidal OJ, Diz P, Cobo M, Hernández B, Vázquez Estevez S, Benítez G, Guirado M, Majem M, Bernabé R, Ortega AL, Blasco A, Bosch-Barrera J, Jurado JM, García González J, Viteri S, Garcia Giron C, Massutí B, Lopez Martín A, Rodriguez-Festa A, Calabuig-Fariñas S, Molina-Vila MÁ, Provencio M. Mol Oncol. 2021 Jan;15(1):43-56.
Romero A, Jantus-Lewintre E, García-Peláez B, Royuela A, Insa A, Cruz P, Collazo A, Pérez Altozano J, Vidal OJ, Diz P, Cobo M, Hernández B, Vázquez Estevez S, Benítez G, Guirado M, Majem M, Bernabé R, Ortega AL, Blasco A, Bosch-Barrera J, Jurado JM, García González J, Viteri S, Garcia Giron C, Massutí B, Lopez Martín A, Rodriguez-Festa A, Calabuig-Fariñas S, Molina-Vila MÁ, Provencio M. Mol Oncol. 2021 Jan;15(1):43-56.
dPCR application in liquid biopsies: divide and conquer.
Moreno-Manuel A, Calabuig-Fariñas S, Obrador-Hevia A, Blasco A, Fernández-Díaz A, Sirera R, Camps C, Jantus-Lewintre E.Expert Rev Mol Diagn. 2021 Jan;21(1):3-15.
Moreno-Manuel A, Calabuig-Fariñas S, Obrador-Hevia A, Blasco A, Fernández-Díaz A, Sirera R, Camps C, Jantus-Lewintre E.Expert Rev Mol Diagn. 2021 Jan;21(1):3-15.
Update on systemic treatment in early triple negative breast cancer.
Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, José Godes Sanz de Bremond M, García González C, Torres Martínez S, García-García JÁ, Iranzo González-Cruz V, Camps Herrero C. Ther Adv Med Oncol. 2021 Jan 31;13:1758835920986749
Núñez Abad M, Calabuig-Fariñas S, Lobo de Mena M, José Godes Sanz de Bremond M, García González C, Torres Martínez S, García-García JÁ, Iranzo González-Cruz V, Camps Herrero C. Ther Adv Med Oncol. 2021 Jan 31;13:1758835920986749
A profile on cobas® EGFR Mutation Test v2 as companion diagnostic for first-line treatment of patients with non-small cell lung cancer.
Torres S, González Á, Cunquero Tomas AJ, Calabuig Fariñas S, Ferrero M, Mirda D, Sirera R, Jantus-Lewintre E, Camps C. Expert Rev Mol Diagn. 2020 Jun;20(6):575-582.
Torres S, González Á, Cunquero Tomas AJ, Calabuig Fariñas S, Ferrero M, Mirda D, Sirera R, Jantus-Lewintre E, Camps C. Expert Rev Mol Diagn. 2020 Jun;20(6):575-582.
Safe neoadjuvant trastuzumab-based treatment in HER2 + inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.
Cunquero-Tomás AJ, Ávila-Andrade CD, Milara J, Javier K, Iranzo V, Camps C. J Oncol Pharm Pract. 2020 Mar;26(2):492-495.
Cunquero-Tomás AJ, Ávila-Andrade CD, Milara J, Javier K, Iranzo V, Camps C. J Oncol Pharm Pract. 2020 Mar;26(2):492-495.
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
Dómine M, Moran T, Isla D, Martí JL, Sullivan I, Provencio M, Olmedo ME, Ponce S, Blasco A, Cobo M. Clin Transl Oncol. 2020 Feb;22(2):245-255.
Dómine M, Moran T, Isla D, Martí JL, Sullivan I, Provencio M, Olmedo ME, Ponce S, Blasco A, Cobo M. Clin Transl Oncol. 2020 Feb;22(2):245-255.
Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study.
Fernandez-Serra A, Moura DS, Sanchez-Izquierdo MD, Calabuig-Fariñas S, Lopez-Alvarez M, Martínez-Martínez A, Carrasco-Garcia I, Ramírez-Calvo M, Blanco-Alcaina E, López-Reig R, Obrador-Hevia A, Alemany R, Gutierrez A, Hindi N, Poveda A, Lopez-Guerrero JA, Martin-Broto J. Cancers (Basel). 2020 Oct 14;12(10):2979.
Fernandez-Serra A, Moura DS, Sanchez-Izquierdo MD, Calabuig-Fariñas S, Lopez-Alvarez M, Martínez-Martínez A, Carrasco-Garcia I, Ramírez-Calvo M, Blanco-Alcaina E, López-Reig R, Obrador-Hevia A, Alemany R, Gutierrez A, Hindi N, Poveda A, Lopez-Guerrero JA, Martin-Broto J. Cancers (Basel). 2020 Oct 14;12(10):2979.
Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q.
Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S. J Thorac Dis. 2020 May;12(5):2771-2780.
Song Y, Jia Z, Wang Y, Wang Y, Liu P, Zhang S, Bing Z, Cao L, Cao Z, Rossi E, Zamarchi R, Denis MG, Camps C, Fernandez-Diaz AB, Liang N, Li S. J Thorac Dis. 2020 May;12(5):2771-2780.
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.
Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R.Cells. 2020 Feb 24;9(2):522.
Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R.Cells. 2020 Feb 24;9(2):522.
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB).
Rolfo C, Cardona AF, Cristofanilli M, Paz-Ares L, Diaz Mochon JJ, Duran I, Raez LE, Russo A, Lorente JA, Malapelle U, Gil-Bazo I, Jantus-Lewintre E, Pauwels P, Mok T, Serrano MJ; ISLB.Crit Rev Oncol Hematol. 2020 Jul;151:102978.
Rolfo C, Cardona AF, Cristofanilli M, Paz-Ares L, Diaz Mochon JJ, Duran I, Raez LE, Russo A, Lorente JA, Malapelle U, Gil-Bazo I, Jantus-Lewintre E, Pauwels P, Mok T, Serrano MJ; ISLB.Crit Rev Oncol Hematol. 2020 Jul;151:102978.
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.
Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, Zúñiga S, Saenger Y, Rosell R, Camps C, Lozano F, Sirera R. Transl Lung Cancer Res. 2020 Aug;9(4):1074-1083.
Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, Zúñiga S, Saenger Y, Rosell R, Camps C, Lozano F, Sirera R. Transl Lung Cancer Res. 2020 Aug;9(4):1074-1083.
Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR.
Esteva-Socias M, Enver-Sumaya M, Gómez-Bellvert C, Guillot M, Azkárate A, Marsé R, Sastre Ú, Blasco A, Calabuig-Fariñas S, Asensio VJ, Terrasa J, Obrador-Hevia A. Front Med (Lausanne). 2020 Nov 13;7:594900.
Esteva-Socias M, Enver-Sumaya M, Gómez-Bellvert C, Guillot M, Azkárate A, Marsé R, Sastre Ú, Blasco A, Calabuig-Fariñas S, Asensio VJ, Terrasa J, Obrador-Hevia A. Front Med (Lausanne). 2020 Nov 13;7:594900.